Skip to main content

Table 4 Concentrations of serum cystatin C and neutrophil gelatinase-associated lipocalin in patients with and without renal dysfunction at hospital admission, n = 357

From: Serum neutrophil gelatinase-associated lipocalin has an advantage over serum cystatin C and glomerular filtration rate in prediction of adverse cardiovascular outcome in patients with ST-segment elevation myocardial infarction

Feature

Renal dysfunction at hospital admission, n = 104

No renal dysfunction at hospital admission, n = 253

P value

Serum cystatin C on the 1st day after hospital admission, mg/L

1.76 (1.06–1.96)

1.16 (0.86–1.34)

0.037

Serum cystatin C on the 12th-14th day after hospital admission, mg/L

1.75 (1.15–2.16)

1.31 (0.95–1.66)

0.001

Serum neutrophil gelatinase-associated lipocalin on the 1st day after hospital admission, ng/mL

1.41 (1.01–1.82)

1.36 (1.08–1.64)

0.95

Serum neutrophil gelatinase-associated lipocalin on the 12th-14th day after hospital admission, ng/mL

1.78 (1.43–2.12)

1.85 (1.65–2.06)

0.68